Metabolic disposition of the anti-cancer agent [(14)C]laromustine in male rats

por Nassar, Ala F., Wisnewski, Adam, King, Ivan
Publicado en Xenobiotica (2015)

Impact of recent innovations in the use of mass cytometry in support of drug development

por Nassar, Ala F., Ogura, Hideki, Wisnewski, Adam V.
Publicado en Drug Discov Today (2015)

Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization

por Nassar, Ala F., Wisnewski, Adam V., Raddassi, Khadir
Publicado en Anal Bioanal Chem (2017)

LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2’ and 2,4’ vs. 4,4’) of Methylene Diphenyl-Diisocyanate

por Wisnewski, Adam V, Liu, Jian, Nassar, Ala F
Publicado en EC Pharmacol Toxicol (2019)

Di-Lysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure?

por Wisnewski, Adam V., Nassar, Ala F, Liu, Jian, Bello, Dhimiter
Publicado en Chem Res Toxicol (2019)

UPLC–MS for metabolomics: a giant step forward in support of pharmaceutical research

por Nassar, Ala F., Wu, Terence, Nassar, Samuel F., Wisnewski, Adam V.
Publicado en Drug Discov Today (2016)

Polymerization of hexamethylene diisocyanate in solution and a 260.23 m/z [M+H](+) ion in exposed human cells

por Wisnewski, Adam V, Liu, Jian, Redlich, Carrie A, Nassar, Ala F
Publicado en Anal Biochem (2017)

Reaction products of hexamethylene diisocyanate vapors with “self” molecules in the airways of rabbits exposed via tracheostomy

por Wisnewski, Adam V., Kanyo, Jean, Asher, Jennifer, Goodrich, James A., Barnett, Grace, Patrylak, Lyn, Liu, Jian, Redlich, Carrie A., Nassar, Ala F.
Publicado en Xenobiotica (2017)